Abstract
Hypercholesterolemia and oxidative stress have been implicated in the pathophysiology of atherosclerosis and coronary artery disease. We investigated whether the carotenoid bixin (BIX) may reduce oxidative damage, inflammatory response, and the atherosclerotic lesion induced by hypercholesterolemia in rabbits. Rabbits received regular chow (control) or a hypercholesterolemic diet (0.5 % cholesterol) alone or supplemented with BIX (10, 30 or 100 mg/kg body weight, b.w.) or simvastatin (15 mg/kg b.w.) for 60 days. Treatment with BIX or simvastatin reduced the atherosclerotic lesions in cholesterol-fed rabbits (up to 55 and 96 % reduction, respectively). This protective effect of BIX was accompanied by decrease in the levels of tumor necrosis factor alpha by 15 %, interleukin 6 by 19 %, lipid peroxidation by 60 %, non-high-density lipoprotein cholesterol (non-HDL-C) by 37 %, and triglycerides by 41 %. BIX increased by 160 % the HDL-C levels and decreased by 67 % the atherogenic index of hypercholesterolemic rabbits. In atherosclerotic rabbits, the non-protein thiol groups content and the activity of the antioxidant enzymes superoxide dismutase, catalase, glutathione reductase, and thioredoxin reductase were increased in the aortic tissue, whereas paraoxonase activity was reduced in the serum. All these changes were completely prevented by BIX or simvastatin treatment. These results demonstrate that BIX reduces the extent of atherosclerotic lesions and this effect was associated with the decrease in oxidative stress, inflammatory response, and improvement of dyslipidemia, which were most effectively controlled after treatment with 10–30 mg BIX/kg b.w. BIX consumption may, therefore, be an adjuvant to prevent atherosclerosis reducing risk factors for coronary diseases.
Similar content being viewed by others
References
Douglas G, Channon KM (2014) The pathogenesis of atherosclerosis. Medicine (Baltimore). doi:10.1016/j.mpmed.2014.06.011
Jamkhande PG, Chandak PG, Dhawale SC et al (2014) Therapeutic approaches to drug targets in atherosclerosis. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc 22:179–190. doi:10.1016/j.jsps.2013.04.005
Chávez-Sánchez L, Espinosa-Luna JE, Chávez-Rueda K et al (2014) Innate immune system cells in atherosclerosis. Arch Med Res 45:1–14. doi:10.1016/j.arcmed.2013.11.007
Pineda A, Cubeddu LX (2011) Statin rebound or withdrawal syndrome: does it exist? Curr Atheroscler Rep 13:23–30. doi:10.1007/s11883-010-0148-x
Puccetti L, Pasqui AL, Scarpini F et al (2011) Statins discontinuation in compliant chronic users induces atherothrombotic profile despite baseline clinical setting and treatments. Int J Cardiol 153:328–329. doi:10.1016/j.ijcard.2011.09.042
Roehrs M, Figueiredo CG, Zanchi MM et al (2014) Bixin and norbixin have opposite effects on glycemia, lipidemia, and oxidative stress in streptozotocin-induced diabetic rats. Int J Endocrinol. doi:10.1155/2014/839095
Anandhi R, Thomas PA, Geraldine P (2014) Evaluation of the anti-atherogenic potential of chrysin in Wistar rats. Mol Cell Biochem 385:103–113. doi:10.1007/s11010-013-1819-z
Lima LRP, Oliveira TT, Nagem TJ, Pacheco S (2010) Flavonoids and natural urucum dyes on induced hyperlipidemic rabbits. Rev Bras Análises Clínicas 42:69–74
Xu X, Pan J, Zhou X (2014) Amelioration of lipid profile and level of antioxidant activities by epigallocatechin-gallate in a rat model of atherogenesis. Heart Lung Circ 23:1194–1201. doi:10.1016/j.hlc.2014.05.013
Lönn ME, Dennis JM, Stocker R (2012) Actions of “antioxidants” in the protection against atherosclerosis. Free Radic Biol Med 53:863–884. doi:10.1016/j.freeradbiomed.2012.05.027
Yu X-H, Fu Y-C, Zhang D-W et al (2013) Foam cells in atherosclerosis. Clin Chim Acta 424:245–252. doi:10.1016/j.cca.2013.06.006
Vaisi-Raygani A, Ghaneialvar H, Rahimi Z et al (2011) Paraoxonase Arg 192 allele is an independent risk factor for three-vessel stenosis of coronary artery disease. Mol Biol Rep 38:5421–5428. doi:10.1007/s11033-011-0696-3
Rajendran P, Nandakumar N, Rengarajan T et al (2014) Antioxidants and human diseases. Clin Chim Acta 436C:332–347. doi:10.1016/j.cca.2014.06.004
Kaulmann A, Bohn T (2014) Carotenoids, inflammation and oxidative stress—implications of cellular signaling pathways and relation to chronic disease prevention. Nutr Res. doi:10.1016/j.nutres.2014.07.010
Giuliano G, Rosati C, Bramley PM (2003) To dye or not to dye: biochemistry of annatto unveiled. Trends Biotechnol 21:513–516. doi:10.1016/j.tibtech.2003.10.001
Levy LW, Regalado E, Navarrete S, Watkins RH (1997) Bixin and norbixin in human plasma: determination and study of the absorption of a single dose of annatto food color. Analyst 122:977–980. doi:10.1039/a701304c
Chisté RC, Mercadante AZ, Gomes A et al (2011) In vitro scavenging capacity of annatto seed extracts against reactive oxygen and nitrogen species. Food Chem 127:419–426. doi:10.1016/j.foodchem.2010.12.139
Montenegro MA, de Rios AO, Mercadante AZ et al (2004) Model studies on the photosensitized isomerization of bixin. J Agric Food Chem 52:367–373. doi:10.1021/jf0349026
Silva CR, Antunes LM, Bianchi ML (2001) Antioxidant action of bixin against cisplatin-induced chromosome aberrations and lipid peroxidation in rats. Pharmacol Res 43:561–566. doi:10.1006/phrs.2001.0822
Rao MP, Manjunath K, Bhagawati ST, Thippeswamy BS (2014) Bixin loaded solid lipid nanoparticles for enhanced hepatoprotection—preparation, characterisation and in vivo evaluation. Int J Pharm 473:485–492. doi:10.1016/j.ijpharm.2014.07.027
Russell KRM, Omoruyi FO, Pascoe KO, Morrison EYSA (2008) Hypoglycaemic activity of Bixa orellana extract in the dog. Methods Find Exp Clin Pharmacol 30:301–305. doi:10.1358/mf.2008.30.4.1186073
Barcelos GRM, Angeli JPF, Serpeloni JM et al (2009) Effect of annatto on micronuclei induction by direct and indirect mutagens in HepG2 cells. Environ Mol Mutagen 50:808–814. doi:10.1002/em.20494
Agner AR, Barbisan LF, Scolastici C, Salvadori DMF (2004) Absence of carcinogenic and anticarcinogenic effects of annatto in the rat liver medium-term assay. Food Chem Toxicol 42:1687–1693. doi:10.1016/j.fct.2004.06.005
Paumgartten FJR, De-Carvalho RR, Araujo IB et al (2002) Evaluation of the developmental toxicity of annatto in the rat. Food Chem Toxicol 40:1595–1601. doi:10.1016/S0278-6915(02)00133-3
Tully TN Jr, Tully TN, Mitchell MA (2012) A veterinary Technician’s guide to exotic animal care, 2nd ed. Can Vet J 43:257
Manning PJ, Ringler DH, Newcomer CE (1994) The biology of the laboratory rabbit, 2nd edn. Academic Press, Waltham, p 483
Bolayirli IM, Aslan M, Balci H et al (2007) Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine. Life Sci 81:121–127. doi:10.1016/j.lfs.2007.04.027
Haidari M, Ali M, Gangehei L et al (2010) Increased oxidative stress in atherosclerosis-predisposed regions of the mouse aorta. Life Sci 87:100–110. doi:10.1016/j.lfs.2010.05.016
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358. doi:10.1016/0003-2697(79)90738-3
Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77. doi:10.1016/0003-9861(59)90090-6
Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170–3175
Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126
Carlberg I, Mannervik B (1979) Inhibition of glutathione reductase by interaction of 2,4,6-trinitrobenzenesulfonate with the active-site dithiol. FEBS Lett 98:263–266. doi:10.1016/0014-5793(79)80196-9
Holmgren A, Björnstedt M (1995) Thioredoxin and thioredoxin reductase. Methods Enzymol 252:199–208. doi:10.1016/0076-6879(95)52023-6
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Augusti PR, Conterato GMM, Somacal S et al (2009) Astaxanthin reduces oxidative stress, but not aortic damage in atherosclerotic rabbits. J Cardiovasc Pharmacol Ther 14:314–322. doi:10.1177/1074248409350136
Buja LM (2014) Nikolai N. Anitschkow and the lipid hypothesis of atherosclerosis. Cardiovasc Pathol 23:183–184. doi:10.1016/j.carpath.2013.12.004
Pereira T (2012) Dyslipidemia and cardiovascular risk: lipid ratios as risk factors for cardiovascular disease. In: Kelishadi R (ed) Dyslipidemia—from prev. to treat. InTech, Rijeka, pp 279–302
Song S, Ovbiagele B (2009) Management of risk factors for accelerated atherosclerosis. Curr Treat Options Neurol 11:460–472. doi:10.1007/s11940-009-0050-4
Lima LRP, Oliveira TT, Nagem TJ et al (2008) Therapeutic action and inocuity on the metabolism of quercetin, bixin and norbixin in rabbits hyperlipidemics. Tecnol Ciência Agropecuária 2:51–56
Santos AA, Silva MV, Guerreiro LT et al (2002) Influence of norbixin on plasma cholesterol-associated lipoproteins, plasma arylesterase/paraoxonase activity and hepatic lipid peroxidation of Swiss mice on a high fat diet. Food Chem 77:393–399. doi:10.1016/S0308-8146(01)00363-6
Matuo MC, Takamoto RTO, Kikuchi IS, Pinto TJA (2013) Effect of bixin and norbixin on the expression of cytochrome P450 in HepG2 cell line. Cell Biol Int 37:843–848. doi:10.1002/cbin.10108
Goto T, Takahashi N, Kato S et al (2012) Bixin activates PPARα and improves obesity-induced abnormalities of carbohydrate and lipid metabolism in mice. J Agric Food Chem 60:11952–11958. doi:10.1021/jf303639f
Eliasson B, Cederholm J, Eeg-Olofsson K et al (2011) Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register. Diabetes Care 34:2095–2100. doi:10.2337/dc11-0209
Di Mascio P, Kaiser S, Sies H (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274:532–538. doi:10.1016/0003-9861(89)90467-0
Van Diepen JA, Berbée JFP, Havekes LM, Rensen PCN (2013) Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis. Atherosclerosis 228:306–315. doi:10.1016/j.atherosclerosis.2013.02.028
Takahashi N, Goto T, Taimatsu A et al (2009) Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARgamma activation. Biochem Biophys Res Commun 390:1372–1376. doi:10.1016/j.bbrc.2009.10.162
Choi J-M, Bothwell ALM (2012) The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases. Mol Cells 33:217–222. doi:10.1007/s10059-012-2297-y
Calabrese EJ (2008) Hormesis and medicine. Br J Clin Pharmacol 66:594–617. doi:10.1111/j.1365-2125.2008.03243.x
Van Diepen JA, Wong MC, Guigas B et al (2011) Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice. J Lipid Res 52:942–950. doi:10.1194/jlr.M010405
Thiruchenduran M, Vijayan NA, Sawaminathan JK, Devaraj SN (2011) Protective effect of grape seed proanthocyanidins against cholesterol cholic acid diet-induced hypercholesterolemia in rats. Cardiovasc Pathol 20:361–368. doi:10.1016/j.carpath.2010.09.002
Ishii T, Itoh K, Ruiz E et al (2004) Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 94:609–616. doi:10.1161/01.RES.0000119171.44657.45
Aviram M, Rosenblat M, Billecke S et al (1999) Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 26:892–904. doi:10.1016/S0891-5849(98)00272-X
Sposito AC, Carvalho LSF, Cintra RMR et al (2009) Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal. Atherosclerosis 207:191–194. doi:10.1016/j.atherosclerosis.2009.04.008
Sabuhi R, Ali Q, Asghar M et al (2011) Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats. Am J Physiol Renal Physiol 300:F700–F706. doi:10.1152/ajprenal.00616.2010
Acknowledgments
This work was supported by fellowships from National Council for Scientific and Technological Development (CNPq) and Co-ordination for the Improvement of Higher Education Staff (CAPES) and had financial support from CNPq (475597/2010-9 and 552440/2011-6) and Edital Capes 11/2009 and 27/2010 - Pró-Equipamentos Institucional. The authors thank Christian Hansen Co., Ltd., Denmark, for the kind donation of the BIX product and Doles, Brazil, for the kind donation of biochemical kits.
Conflict of interest
All authors declare that there are no funding sources, employment, or personal financial competing interests that could influence the position presented in this manuscript. In addition, authors are not aware of any institutional competing interest of any nature or kind.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Somacal, S., Figueiredo, C.G., Quatrin, A. et al. The antiatherogenic effect of bixin in hypercholesterolemic rabbits is associated to the improvement of lipid profile and to its antioxidant and anti-inflammatory effects. Mol Cell Biochem 403, 243–253 (2015). https://doi.org/10.1007/s11010-015-2354-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-015-2354-x